MDLN
Medline·NASDAQ
--
--(--)
--
--(--)
MDLN fundamentals
Medline (MDLN) released its earnings on Feb 25, 2026: revenue was 7.79B (YoY --), beat estimates; EPS was -0.01 (YoY --), missed estimates.
Revenue / YoY
7.79B
--
EPS / YoY
-0.01
--
Report date
Feb 25, 2026
MDLN Earnings Call Summary for Q4,2025
- Revenue Growth: 12% YoY to $28.4 billion, driven by new signings and Medline Brand conversions.
- Automation Leap: 19 AutoStore facilities, 2,100 robots, and Symbotic bulk-picking pilot to boost efficiency.
- Tariff Headwinds: 2026 incremental impact $200 million, partially mitigated by production shifts and pricing.
- Strategic Wins: Consolidated IDN win and $2.4B signings highlight end-to-end care model success.
- Financial Strength: $7B IPO reduces leverage, with $1.3B free cash flow and $3.5B EBITDA in 2025.
EPS
Actual | -0.01 |
Forecast | 0.238 |
Surprise | -104.20% |
Revenue
Actual | 7.79B |
Forecast | 7.51B |
Surprise | +3.66% |
Earnings Call
You can ask Aime
What is Medline's gross profit margin?What guidance did Medline's management provide for the next earnings period?What were the key takeaways from Medline's earnings call?What is the market's earnings forecast for Medline next quarter?What is the revenue and EPS growth rate for Medline year over year?What factors drove the changes in Medline's revenue and profit?What does Medline do and what are its main business segments?Did Medline beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
